TOP STORIES

• ACADEMIA Obesity Med Wegovy Could Be “Ace in the Hole”, Should Avoid Fate of Oblean: KOL
  March 30, 2023

• REGULATORY Japan Approves Wegovy, Omvoh, FluMist, Entyvio SC and More
  March 28, 2023

• BUSINESS Novartis Japan Sees 2023 OK for 1st siRNA Drug for Hyperlipidemia, 7 Approvals to Drive Growth
  March 27, 2023

• ORGANIZATION Japan Umbrella Trade Organ to Beef Up Functions for Lobbying Activity
  March 24, 2023

• REGULATORY Generic Dispensing Tops 82%; 57% of Pharmacies Not Active on Biosimilars: Poll
  March 23, 2023

• REGULATORY MHLW Council Discusses Root Causes of Drug Supply Disruptions, Yakkasa Issues
  March 22, 2023

• REGULATORY Expert Panel Talks over Yakkasa, Revamp of Price Revision Method; Fixed Margin, Claw-Back Mooted
  March 20, 2023

• BUSINESS CSL R&D Head Touts Cost-Effectiveness of Hemophilia Gene Therapy Hemgenix
  March 17, 2023

• BUSINESS Illumina Eyes Japan Launch of Comprehensive Genomic Profiling Test This Year
  March 16, 2023

• BUSINESS Teijin Pharma Plans Pivot to Rare Diseases as Generics Eat into Feburic Sales
  March 15, 2023

• BUSINESS Eisai’s Leqembi Wins Coverage from US Veteran’s Body
  March 15, 2023

• BUSINESS Bayer Setting Out to Cut Up to 480 Jobs as Xarelto Patent Cliff Looms: Employee
  March 14, 2023

• BUSINESS AstraZeneca Looks to 1st IO/ADC Launch as Leader in the Race: Oncology Head
  March 13, 2023

• ORGANIZATION PhRMA Unveils Proposal for FY2024 Reform, Says This Year Is “Turning Point” to Improve Access
  March 10, 2023

• REGULATORY Xocova Priced at 51,851 Yen per Course with Peak Sales Put at 19.2 Billion Yen
  March 9, 2023

• REGULATORY Expert Narukawa Backs JPMA Pitch on Value-Based Pricing, but Disputes Blanket Price Maintenance for Patented Meds
  March 8, 2023

• BUSINESS Azilva, Abraxane, and More Major Meds Get Add-On PMPs under Ad-Hoc Rule in FY2023: Poll
  March 7, 2023

• BUSINESS Drug Makers Wary of Rush Demand Tied to Unprofitability Re-Pricing, Some Curb Orders
  March 7, 2023

• BUSINESS 2023 Price Cut for Top-Tier, 2nd-Tier Firms at 1-4%, Tsumura Only Original Drug Maker to See Net Rise: Jiho Poll
  March 6, 2023

• REGULATORY MHLW Unveils New List Prices for FY2023 Revision, Ad-Hoc PMP Raise for 143 Products
  March 3, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 57
• 58
• 59
• 60
• 61
• 62
• 63
• 64
• 65
• …
• Next ›
• 最終 »